Anthony P. Jansz
Director/Miembro de la Junta en The Medical Finance Co. .
Perfil
Anthony P.
Jansz is currently a Director at The Medical Finance Co. Prior to this, he was a Director at EnteroMedics, Inc. from 2015 to 2016.
He was also a Managing Director at The Carlyle Group, Inc. from 2005 to 2005.
Additionally, he served as Chairman at The Australian Institute of Weight Control in 2011.
Cargos activos de Anthony P. Jansz
Empresas | Cargo | Inicio |
---|---|---|
The Medical Finance Co. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Anthony P. Jansz.
Empresas | Cargo | Fin |
---|---|---|
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Director/Miembro de la Junta | 12/08/2016 |
The Australian Institute of Weight Control | Presidente | 01/03/2011 |
THE CARLYLE GROUP INC. | Corporate Officer/Principal | 01/01/2005 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
THE CARLYLE GROUP INC. | Finance |
Empresas privadas | 3 |
---|---|
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
The Australian Institute of Weight Control | |
The Medical Finance Co. |
- Bolsa de valores
- Insiders
- Anthony P. Jansz